Cargando…

MASTL: A novel therapeutic target for Cancer Malignancy

Targeting mitotic kinases is an emerging anticancer approach with promising preclinical outcomes. Microtubule‐associated serine/threonine kinase like (MASTL), also known as Greatwall (Gwl), is an important mitotic kinase that regulates mitotic progression of normal or transformed cells by blocking t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fatima, Iram, Singh, Amar B., Dhawan, Punita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476815/ https://www.ncbi.nlm.nih.gov/pubmed/32692487 http://dx.doi.org/10.1002/cam4.3141

Ejemplares similares

MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling
por: Uppada, Srijayaprakash Babu, et al.
Publicado: (2018)

Kinase-Independent Functions of MASTL in Cancer: A New Perspective on MASTL Targeting
por: Conway, James Ronald William, et al.
Publicado: (2020)

The Oncogenic Functions of MASTL Kinase
por: Marzec, Kamila, et al.
Publicado: (2018)

Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells
por: Barman, Susmita, et al.
Publicado: (2021)

Mastl kinase, a promising therapeutic target, promotes cancer recurrence
por: Wang, Ling, et al.
Publicado: (2014)

Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and Oocytes
por: Kang, Minsung, et al.
Publicado: (2021)

Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications
por: Ahmad, Rizwan, et al.
Publicado: (2016)

The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery
por: Li, Yanqiu, et al.
Publicado: (2023)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

ITGB4 as a novel serum diagnosis biomarker and potential therapeutic target for colorectal cancer
por: Jiang, Xia, et al.
Publicado: (2021)

Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer
por: Wang, Juan, et al.
Publicado: (2018)

Challenges in validating candidate therapeutic targets in cancer
por: Settleman, Jeffrey, et al.
Publicado: (2018)

Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling
por: Gargano, Stacey M., et al.
Publicado: (2019)

MicroRNA‐124: An emerging therapeutic target in cancer
por: Jia, Xinqi, et al.
Publicado: (2019)

MASTL overexpression promotes chromosome instability and metastasis in breast cancer
por: Rogers, Samuel, et al.
Publicado: (2018)

Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation
por: Polisety, Aneesha, et al.
Publicado: (2022)

Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy
por: Mishra, Rangnath, et al.
Publicado: (2020)

Mucosal healing and inflammatory bowel disease: Therapeutic implications and new targets
por: Otte, Megan Lynn, et al.
Publicado: (2023)

Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer
por: Whitton, Bradleigh, et al.
Publicado: (2018)

Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer
por: Miwa, Tomohiro, et al.
Publicado: (2015)

A novel intraperitoneal therapy for gastric cancer with DFP‐10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model
por: Ando, Hidenori, et al.
Publicado: (2019)

Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer
por: Álvarez-Fernández, Mónica, et al.
Publicado: (2017)

Ectokinases as novel cancer markers and drug targets in cancer therapy
por: Yalak, Garif, et al.
Publicado: (2015)

Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer
por: Cato, Laura, et al.
Publicado: (2017)

SILAC kinase screen identifies potential MASTL substrates
por: Marzec, Kamila A., et al.
Publicado: (2022)

Claudin Family of Proteins and Cancer: An Overview
por: Singh, Amar B., et al.
Publicado: (2010)

Three‐dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer
por: Falkenberg, Natalie, et al.
Publicado: (2016)

Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy
por: Gowrikumar, Saiprasad, et al.
Publicado: (2019)

The MASTL-ENSA-PP2A/B55 axis modulates cisplatin resistance in oral squamous cell carcinoma
por: Gouttia, Odjo G., et al.
Publicado: (2022)

Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma
por: Guetta-Terrier, Charlotte, et al.
Publicado: (2023)

Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer
por: Dayan, Dan, et al.
Publicado: (2012)

Novel ATP‐competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells
por: Yamaji, Masayuki, et al.
Publicado: (2017)

Proteomic profiling of FBXW7‐mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target
por: Urick, Mary Ellen, et al.
Publicado: (2020)

Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer
por: Theard, Patricia L, et al.
Publicado: (2020)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
por: Aird, Fraser, et al.
Publicado: (2017)

Mastl/PP2A regulate Cdk1 in ooycte maturation
por: Adhikari, Deepak, et al.
Publicado: (2015)

Novel therapeutic roles of MC‐4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways
por: Son, Ji Yeon, et al.
Publicado: (2018)

A novel tumor suppressor SPINK5 targets Wnt/β‐catenin signaling pathway in esophageal cancer
por: Wang, Qian, et al.
Publicado: (2019)

peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas
por: Martínez‐Sáez, Elena, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hmi0lhpliv7h37bca1tmt8vpvi